Proposal project

Running head: PROPOSAL FOR TRANSEASOPHAGEAL DISINFECTION 1 Proposal for Transesophageal Disin fection System Student Name Adventist University of Health Sciences PROPOSAL FOR TRANSESOPHAGEAL DISINFECTION 2 Executive Summary Non invasive cardiology is currently having issues with a transesophageal echocardiology (TEE) disinfector. There is only one disinfector and it is currently out of order . This will have a four week turnaround time. This poses a problem because there is only one machine. The current solution requires sending the machine to the company for repair and using the equipment that is th e property of the operating suite. The operating suite has two machines, but they are having mechanical issues with one o f their machines. PROPOSAL FOR TRANSESOPHAGEAL DISINFECTION 3 Problem Identification In 2009, the Heart, Lung and Mechanical Cardiac Assist Program was established . By 2013, there were 70 ve ntricular assist devices (VADs) implanted and 33 heart transplants. To date 216 VAD s have been implanted, 42 lung transplants, one lung transplant and 59 heart transplan ts. The benefits of resolving this problem wil l be to increase productivity , and turnover time . More procedures can be done in a shorter period of time. A PEST was done to evaluate the forces that should be considered in the decision making process . The chart (Fig. 1) illustrates the forces identified. Political Forces Economic Forces Social Forces Technological forces National institutes for health funding - decline in pharmaceutical sales due to patent expirations and decline in new drug therapies. This causes reduction in public funding worldwide. Increase in revenue - with an increase in tests the machines will pay for themselves faster Increased patient satisfaction - increased Press - Gainey score - Patient satisfaction. Technologists will be able to turn the rooms over quicker - providing reports faster and availability to do more tests. Federal drug administration -drug lawsuits for drugs that are used for some of the disease processes can slow the approval of new drugs. Single d evice inventions - pose a single time fix instead of years of expensive drug therapy Same day procedure and reduction of frequent blood test visits to check of therapeutic levels. More machines will make more tests possible - less equipment fatigue and failure. Affordable care act - imposing new fees on the pharmaceutical manufacturing sector Advantage of technology - Economies of scale Reduction of cost - drug therapy important to patients. Reduction in nosocomial infection - of patient PROPOSAL FOR TRANSESOPHAGEAL DISINFECTION 4 of 2.8 -4.1 billion each year from 2012 -2019. causes per test cost to decrease. due to better sanitation practice. Affordable care act - other hospitals in the area are p artnering with larger facilities to provide some of these services that have only been offered here.

Competition will increase for some of these services. Abilit y to increase number of tests - the ability of opening another procedure room. Matching performa nce with patient expectations -patient expectations of timely testing staying on schedule. Technologist’s safety -technologists are not exposed to chemicals. Figure 1- PEST analysis There has been a decline in the approval of the number of chemicals that become drugs directed towards cardiovascular disease by the federal drug administration (FDA) since 1999. Description of plan The solu tion should be the purchase of three new TEE disinfectors. Significance This solution will resolve the problem of ever having to go without a unit to disinfect pro bes for four weeks when there are a t least 40 -50 procedures scheduled for that time period and the unknown number of unscheduled inpatients. Methods There is one vendor. Due to the exclusivity of the product, it is not recommended to have one unit with the volume of studies done. PROPOSAL FOR TRANSESOPHAGEAL DISINFECTION 5 Problems There are potential problems in the current budget as money has been slated for some construc tion that has gone over b udget. The amount of $62,000 may have to come from a source that will set back plans that are already earmarked and in the works. Current volumes can replace the money in two -three months and can replace money for a project that is already on hold. Budget Proposed Budget 2016 Transesophageal probe disinfector $10,000 3 $30,000 * Transducer cabinet $0 $0 Plumbing $2,225 1 $2,225 Electrical $500 2 $1,000 Room outfit $0 $0 Discount for buying multiples $1,000 3 -$3,000 Components $3 0,225 Monthly supplies for the year Case of solution (32 bottles) $250 24 $6,000 Case of cleaning sponges(50 sponges) $250 12 $3,000 Case of printer paper (5 rolls) $12 52 $624 Air Filter $395 1 $395 Neutralization kit $125 2 $250 Supplies $10 ,269 Maintenance Repair $3,000 -$4,000 2 $6,000 -$8,000 PROPOSAL FOR TRANSESOPHAGEAL DISINFECTION 6 Shipping parts and service $5,000 2 $10,000 Preventative maintenance $300 (3 machines) 12 $3,600 Maintenance budget $21,600 Entire budget $62 ,094 *The disinfector company will offer a discount of $1,000 off for purchase of multiples. The current charge per TEE is approximately $1,000 -1,500 per study (the higher rate includes an anesthesiologist). At $1,200 per study and 10 studies average per f ive day week, the equipment will pay for itself in two -three months. This includes potential maintenance plan. Timeline The timeline, barring unforeseen problems should take four -eight weeks. PROPOSAL FOR TRANSESOPHAGEAL DISINFECTION 7 References Laslett, L. J., Alagona, J., Peter, Clark, 3., Bernard A, Drozda, J., Joseph P, Saldivar, F., Wilson, S. R.. . Hart, M. (2012). The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the american college of cardiology. Journal of the American College of Cardiology, 60 (25 Suppl), S1. Rut ala , W.A., Weber, D.J. , (HIPAC ) 3. (2008). Guidelines for disinfection and sterilization in healthcare facilities 2008. Centers for Disease Control . Retrieved from http ://www.cdc.gov/hicpac/Disinfection_Sterilization/3_1deLaparoArthro.html